EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanism of Pingchuanning in Attenuating Asthma Based on UHPLC‐Q‐Orbitrap HRMS and Network Pharmacology Analysis

Yue Zhang iD, Yiwen Ding iD, Weidong Chen iD, Yuanbo Bi, Yanyan Wang, Weidong Ye, Xiangming Fang

Biomedical Chromatography · 2026-12 · 40 (12)

DOI: 10.1002/bmc.70607 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 19.10.2026. Verfasst von Yue Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Anhui University of Chinese Medicine, Hefei, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Asthma, Anti-Asthmatic Agents. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui University of Chinese Medicine, Postdoctoral Research Project of the Department of Human Resources and Social Security of Anhui Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An ultrahigh‐performance liquid chromatography coupled with quadrupole‐Orbitrap high‐resolution mass spectrometry (UHPLC‐Q‐Orbitrap HRMS) method was applied to characterize Pingchuanning (PCN) decoction and its absorbed serum constituents in asthmatic rats. A total of 107 compounds were identified in PCN, of which 36 prototypes were detected in rat serum. Network pharmacology and molecular docking of these absorbed compounds predicted ADORA2A as the core therapeutic target, with 5‐ O ‐methylvisammioside, nobiletin, sec ‐ O ‐glucosylhamaudol, and 9‐oxo‐ODE showing binding affinity. In an ovalbumin‐induced asthmatic rat model, PCN alleviated airway hyperresponsiveness and lung inflammation. Mechanistically, PCN upregulated ADORA2A, elevated cAMP and PKA phosphorylation, and suppressed NLRP3 expression. This UHPLC‐Q‐Orbitrap HRMS‐based serum pharmacochemistry method effectively identified the bioactive components of PCN, and the integrated strategy demonstrates that PCN exerts anti‐asthmatic effects through the ADORA2A/cAMP/PKA/NLRP3 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalAsthmaAnti-Asthmatic AgentsAnimalsChromatography, High Pressure LiquidRatsNetwork PharmacologyReceptor, Adenosine A2AMaleMass SpectrometryRats, Sprague-DawleyMolecular Docking Simulation

Stichwörter der Autor:innen

ADORA2APingchuanningUHPLC‐Q‐Orbitrap HRMSasthmanetwork pharmacology

Substanzen

Drugs, Chinese HerbalReceptor, Adenosine A2AAnti-Asthmatic Agents

Autor:innen und Institutionen

  • Anhui University of Chinese Medicine, Hefei, China.
  • School of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei, China.
  • School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China.
  • Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, China.

ORCID-Profile: Yue Zhang, Yiwen Ding, Weidong Chen

Förderung

  • Anhui University of Chinese Medicine
  • Postdoctoral Research Project of the Department of Human Resources and Social Security of Anhui Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y., Ding, Y., Chen, W., Bi, Y., Wang, Y., Ye, W., & Fang, X. (2026). Mechanism of Pingchuanning in Attenuating Asthma Based on UHPLC‐Q‐Orbitrap HRMS and Network Pharmacology Analysis. Biomedical Chromatography, 40(12). https://doi.org/10.1002/bmc.70607

Vancouver

Zhang Y, Ding Y, Chen W, Bi Y, Wang Y, Ye W, et al. Mechanism of Pingchuanning in Attenuating Asthma Based on UHPLC‐Q‐Orbitrap HRMS and Network Pharmacology Analysis. Biomedical Chromatography. 2026;40(12). doi:10.1002/bmc.70607

BibTeX
@article{Zhang2026,
  author = {Zhang, Yue and Ding, Yiwen and Chen, Weidong and Bi, Yuanbo and Wang, Yanyan and Ye, Weidong and Fang, Xiangming},
  title = {Mechanism of Pingchuanning in Attenuating Asthma Based on UHPLC‐Q‐Orbitrap HRMS and Network Pharmacology Analysis},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {12},
  doi = {10.1002/bmc.70607}
}
Kostenlos starten →